<DOC>
	<DOCNO>NCT01909856</DOCNO>
	<brief_summary>This study ass efficacy safety palonosetron prevent acute delay emesis induce 3-day highly emetogenic chemotherapy . A double-blind , crossover design use granisetron positive control .</brief_summary>
	<brief_title>The Efficacy Safety Palonosetron Preventing Gastrointestinal Reactions Induced 3-day Highly Emetogenic Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Emetics</mesh_term>
	<criteria>Patients diagnose malignant tumor receive 3day chemotherapy regimen define protocol ; The twocycle sequential chemotherapy must drug , dosage , sequence route administration ; Patients prohibit chemotherapy drug study , well antiemesis , sedative psychotropic drug within 5 day chemotherapy ; Life expectancy â‰¥ 3 month ; Adequate hematologic function ; Adequate hepatic function ; Adequate renal function ; At least 2 week away last chemotherapy ; Patients sign write informed consent . Pregnant lactating woman ; History anticipatory vomiting ; Radiation therapy abdomen pelvis within one week prior study entry ; Concomitant use drug may affect antiemetic effect ( omeprazole , amifostine , etc . ) ; Patients gastrointestinal obstruction ; Patients severe heart disease , liver renal disease , metabolism disorder ; Patients epilepsy use sedative psychotropic drug ; Patients diabetes contraindication corticosteroid ; Patients receive antiemetic drug experience nausea vomit within 24 hour prior study entry ; Patients brain metastasis intracranial hypertension ; Hypersensitivity 5HT3 receptor antagonist ; Patients active infection ; Other condition investigator consider unsuitable chemotherapy ; Subjects participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>